Showing results (241-250 of 694) with videos related to
Sort By:
Pageof 70
Developments in Biologicals|April 8, 2003
Advanced process monitoring: the ultimate alternativeR Neeleman, C BeuveryDevelopments in Biologicals|April 8, 2003
Antigen content of inactivated Newcastle disease oil emulsion vaccines as an in vitro indicator of potencyR Maas, M van Diepen, M Komen, et al.Developments in Biologicals|May 24, 2003
The immunogenicity of biopharmaceuticals. Lessons learned and consequences for protein drug developmentP A Patten, H SchellekensDevelopments in Biologicals|May 24, 2003
Use of cell-based therapies for modification of host immune responsesH Yeh, C H JuneDevelopments in Biologicals|May 24, 2003
Vailidation of immunoassays for anti-drug antibodiesV H Van CleaveDevelopments in Biologicals|May 24, 2003
Improving the quality of BIACORE-based affinity measurementsM H V Van RegenmortelDevelopments in Biologicals|April 8, 2003
Potency testing of inactivated erysipelas vaccines by ELISA--influence of the adjuvant on antibody developmentU Rosskopf-Streicher, S Johannes, K CusslerDevelopments in Biologicals|April 8, 2003
Validation of a candidate in vitro potency assay for inactivated Newcastle disease vaccinesR Maas, M Komen, H Oei, et al.Developments in Biologicals|April 8, 2003
Novel in vitro functional assays for the determination of anthrax toxin componentsB Hallis, N J Silman, S Noonan, et al.Pageof 70